Nextage Therapeutics Ltd
Nextage Therapeutics Ltd, a pharmaceutical company, develops cannabinoid-based products. The company was formerly known as Nextage Cannabis Innovation Ltd. and changed its name to Nextage Therapeutics Ltd in August 2020. The company was incorporated in 1982 and is based in Ness Ziona, Israel.
Nextage Therapeutics Ltd (NXTG) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of June 2022: -0.730x
Based on the latest financial reports, Nextage Therapeutics Ltd (NXTG) has a cash flow conversion efficiency ratio of -0.730x as of June 2022.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (ILA-1.72 Million) by net assets (ILA2.36 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Nextage Therapeutics Ltd - Cash Flow Conversion Efficiency Trend (2017–2024)
This chart illustrates how Nextage Therapeutics Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Nextage Therapeutics Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Nextage Therapeutics Ltd ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
TRUBF
PINK:TRUBF
|
0.090x |
|
Syncona Limited
LSE:SYNC
|
0.006x |
|
New Mountain Finance Corporation
NASDAQ:NMFC
|
0.018x |
|
PORTMAN RIDGE FIN. DL-01
F:KJ7A
|
N/A |
|
Psyence Group Inc
PINK:PSYGF
|
-0.338x |
|
Crossroads Systems Inc
OTCQX:CRSS
|
1.718x |
|
Margo Caribe Inc
PINK:MRGO
|
-0.012x |
|
Mercer Park Opportunities Corp Ordinary Shares - Class A (Restricted Voting
TO:SPAC-U
|
N/A |
Annual Cash Flow Conversion Efficiency for Nextage Therapeutics Ltd (2017–2024)
The table below shows the annual cash flow conversion efficiency of Nextage Therapeutics Ltd from 2017 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | ILA-5.54 Million | ILA-795.00K | 0.144x | -82.62% |
| 2023-12-31 | ILA-2.74 Million | ILA-2.26 Million | 0.826x | -94.14% |
| 2022-12-31 | ILA-426.00K | ILA-6.01 Million | 14.113x | +283.24% |
| 2021-12-31 | ILA516.00K | ILA-3.97 Million | -7.702x | -76.95% |
| 2020-12-31 | ILA1.45 Million | ILA-6.31 Million | -4.352x | -442.90% |
| 2019-12-31 | ILA3.66 Million | ILA-2.93 Million | -0.802x | -126.70% |
| 2018-12-31 | ILA-1.65 Million | ILA-4.95 Million | 3.003x | +334.96% |
| 2017-12-31 | ILA4.44 Million | ILA-5.67 Million | -1.278x | -- |